Molina Healthcare (NYSE:MOH) Price Target Lowered to $144.00 at Cantor Fitzgerald

Molina Healthcare (NYSE:MOH) had its price objective reduced by equities research analysts at Cantor Fitzgerald from $180.00 to $144.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 9.27% from the company’s previous close.

A number of other research analysts also recently issued reports on MOH. Sanford C. Bernstein reissued an “outperform” rating and set a $224.00 price objective on shares of Molina Healthcare in a research report on Tuesday, January 6th. UBS Group lowered their price objective on shares of Molina Healthcare from $180.00 to $170.00 and set a “neutral” rating for the company in a report on Friday, October 24th. Truist Financial set a $175.00 target price on Molina Healthcare in a report on Friday, October 24th. Morgan Stanley set a $158.00 target price on Molina Healthcare in a research report on Friday, October 24th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Thursday, January 22nd. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $180.07.

Molina Healthcare Trading Down 25.5%

NYSE:MOH opened at $131.78 on Monday. The firm has a market capitalization of $7.14 billion, a P/E ratio of 15.39 and a beta of 0.49. The company has a quick ratio of 1.68, a current ratio of 1.69 and a debt-to-equity ratio of 0.97. The company has a fifty day moving average of $173.19 and a 200 day moving average of $170.69. Molina Healthcare has a 52 week low of $125.00 and a 52 week high of $359.97.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The firm had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. Molina Healthcare’s revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, research analysts predict that Molina Healthcare will post 24.4 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 357 shares of Molina Healthcare stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the completion of the transaction, the director directly owned 11,352 shares of the company’s stock, valued at approximately $1,623,563.04. The trade was a 3.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.26% of the company’s stock.

Institutional Trading of Molina Healthcare

A number of institutional investors have recently made changes to their positions in the stock. Torren Management LLC bought a new position in Molina Healthcare during the fourth quarter valued at approximately $26,000. Miller Global Investments LLC bought a new position in shares of Molina Healthcare during the 4th quarter valued at $27,000. Cromwell Holdings LLC boosted its stake in shares of Molina Healthcare by 211.9% in the 4th quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after buying an additional 125 shares during the last quarter. First Horizon Advisors Inc. boosted its stake in shares of Molina Healthcare by 2,140.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock worth $33,000 after buying an additional 107 shares during the last quarter. Finally, Bogart Wealth LLC bought a new stake in shares of Molina Healthcare in the third quarter worth $39,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.